1. Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19
    Eileen M McGowan et al, 2020, International Journal of Molecular Sciences CrossRef
  2. Targeting the Sphingosine Kinase/Sphingosine-1-Phosphate Signaling Axis in Drug Discovery for Cancer Therapy
    Preeti Gupta et al, 2021, Cancers CrossRef
  3. A Dansyl-Modified Sphingosine Kinase Inhibitor DPF-543 Enhanced De Novo Ceramide Generation
    Maftuna Shamshiddinova et al, 2021, International Journal of Molecular Sciences CrossRef
  4. Glycans Meet Sphingolipids: Structure-Based Design of Glycan Containing Analogues of a Sphingosine Kinase Inhibitor
    Athanasios Papakyriakou et al, 2020, ACS Medicinal Chemistry Letters CrossRef
  5. Modulation of DNA Damage Response by Sphingolipid Signaling: An Interplay that Shapes Cell Fate
    Marina Francis et al, 2020, International Journal of Molecular Sciences CrossRef
  6. Silicon Photomultipliers as a Low-Cost Fluorescence Detector for Capillary Electrophoresis
    Brae V. Petersen et al, 2020, Analytical Chemistry CrossRef
  7. Targeting Chronic Inflammation of the Digestive System in Cancer Prevention: Modulators of the Bioactive Sphingolipid Sphingosine-1-Phosphate Pathway
    Eileen M. McGowan et al, 2022, Cancers CrossRef
  8. New Druggable Targets for Rheumatoid Arthritis Based on Insights From Synovial Biology
    Gurvisha Sandhu et al, 2022, Frontiers in Immunology CrossRef
  9. Synthesis of PP2A-Activating PF-543 Derivatives and Investigation of Their Inhibitory Effects on Pancreatic Cancer Cells
    Su Bin Kim et al, 2022, Molecules CrossRef